Moderna tokenized stock listed on MEXC via Ondo

MEXC has listed the MRNAON/USDT trading pair on its Spot market, providing users access to tokenized Moderna, Inc. stock through Ondo. This move follows a significant surge in Moderna’s share price.

On August 19, 2026, Moderna and Merck announced that their investigational personalized mRNA cancer vaccine, used with Keytruda, met the primary endpoint in a late-stage melanoma trial. The combination regimen successfully extended the time patients lived without the melanoma returning compared to Keytruda alone. Following this announcement, Moderna’s stock price rose 177% in a single session.

The tokenized offering via Ondo allows investors outside the United States to gain exposure to U.S. publicly traded securities. Tokenized stocks have become a significant part of MEXC’s trading activity, accounting for 62% of its total spot trading volume in July.